Preclinical Evaluation of Antimicrobial Nanodrugs

lt;b>Dr. Bueno is currently 'Chief Scientific Officer' of  Research Center of Bioprospecting and Biotechnology for Biodiversity Foundation (BIOLABB). Researcher in Bioprospecting development and consulting. Doctor in medicine from Caldas University, Manizales, Colombia (2001). Master degree in biomedical sciences from Antioquia University, Medellín, Colombia (2008). Expert in design and implementation of antimicrobial platforms for to evaluate natural products and synthesis drugs with the aim of optimize in vitro antimicrobial activity selection of new chemical entities for future anti infective pharmaceutical, Bogotá, Colombia. Fellow, COLCIENCIAS-Universidad de Caldas (2002). Fellow of University of the United Nations in antifungal susceptibility testing, Instituto Nacional de Enfermedades Infecciosas, INEI.ANLIS, Buenos Aires, Argentina (2004). Fellow, International Visitor Leadership Program on "Public Health", United States Department of State, Bureau of Educational and Cultural Affairs (2012), 2221 KONUK VEYA AKADEMIK IZINLI (SABBATICAL) BILIM INSANI DESTEKLEME PROGRAMI (2015). Award of Colombian Dermatology Association, Best research in dermatology (2006). Enrique Nuñez Olarte award for pharmacological research. Colombian Pharmacology Association (2009). Author of 50 articles in pharmacological research. Author in 13 chapter books in antimicrobial drug discovery and bioprospecting as well as the book titled 'MOLECULAR EVOLUTIONARY MODELS IN DRUG DISCOVERY'.

Preface.- 1. Antimicrobial screening, foundations and interpretation.- 2. Antimicrobial activity of nanomaterials, from selection to application.- 3. Synergy and antagonism, the criteria of the formulation.- 4. In vitro Nanotoxicity, towards the development of safe and effective treatments.- 5. ADMETox, bringing nanotechnology closer to Lipinski's rule of five.- 6. Antimicrobial nanotechnology in preventing the transmission of infectious disease.- 7. Nanotechnology in the discovery of new antimicrobial drugs: is a new scientific revolution possible?.- 8. Nanotechnology beyond the antibiosis.- Index.